Mechanisms Underlying Endothelial Dysfunction in Diabetes MellitusTherapeutic Implications
作者:
Ulrich Hink,
Nikos Tsilimingas,
Maria Wendt,
Thomas Münzel,
期刊:
Treatments in Endocrinology
(ADIS Available online 2003)
卷期:
Volume 2,
issue 5
页码: 293-304
ISSN:1175-6349
年代: 2003
出版商: ADIS
关键词: Diabetes mellitus;Endothelial function;Hyperglycaemia
数据来源: ADIS
摘要:
Hyperglycemia is the major causal factor in the development of endothelial dysfunction in patients with diabetes mellitus. Although the mechanisms underlying this phenomenon are likely to be multifactorial, recentin vivoandin vitrostudies have indicated a crucial role of the diacylglycerol (DAG)-protein kinase C (PKC) pathway in mediating this phenomenon. PKC may have multiple adverse effects on vascular function, including the activation of superoxide-producing enzymes such as the nicotinamide adenine dinicleotide phosphate (NADPH) oxidase as well as increased expression of a dysfunctional, superoxide-producing, uncoupled endothelial nitric oxide synthase (NOS III).PKC-mediated superoxide production may inactivate nitric oxide (NO) derived from endothelial NOS III, but also may inhibit the activity and/or expression of the NO downstream target, the soluble guanylyl cyclase. Among the different isoforms of PKC, mainly the β-isoforms have been shown to be activated.Recent studies with selective (isoform-specific) and non-selective PKC inhibitors show that they are able to beneficially influence glucose-induced endothelial dysfunction in experimental animal models as well as in patients, pointing to the therapeutic potential of these compounds in the prevention and treatment of vascular complications of diabetes.
点击下载:
PDF
(319KB)
返 回